This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Hydroxychloroquine for COVID-19

Off-label COVID-19 treatment approach involving hydroxychloroquine, often discussed in early COVID-19 treatment protocols. Hydroxychloroquine was widely discussed early in the COVID-19 pandemic as a possible outpatient or early-treatment agent, including in medical-freedom and early-treatment advocacy circles. Peter A. Mc Cullough has been associated with the broader early-treatment movement that included hydroxychloroquine and other repurposed medications.

Doctors

Dr. Peter A. McCullough, MD, MPH

doctor | America Out Loud Network, American Board of Internal Medicine, Association of American Physicians and Surgeons, Baylor University Medical Center, McCullough Foundation, Texas A&M University College of Medicine, The Wellness Company

Peter A. Mc Cullough, MD, MPH is a Dallas-based internist, cardiologist, epidemiologist, author, podcaster, and prominent COVID-19 early-treatment and vaccine-policy critic. He is president of the Mc Cullough Foundation and Chief Scientific Officer for The Wellness Company. Peter Andrew Mc Cullough, MD, MPH is a U. S.
WebsiteYouTubeWikipedia
All Protocols